Cargando…
Pembrolizumab for Refractory Metastatic Myxofibrosarcoma: A Case Report
Myxofibrosarcoma is a rare tumor, refractory to cytotoxic chemotherapy and radiotherapy. Pembrolizumab is an innovative immunotherapy drug consisting of programmed death receptor ligand 1 antibody proven to be useful for numerous types of cancer cells. A patient had been diagnosed with metastatic my...
Autores principales: | Song, Haa-Na, Kang, Min Gyu, Park, Jeong Rang, Hwang, Jin-Yong, Kang, Jung Hun, Lee, Won Seop, Lee, Gyeong-Won |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Cancer Association
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6192916/ https://www.ncbi.nlm.nih.gov/pubmed/29361819 http://dx.doi.org/10.4143/crt.2017.529 |
Ejemplares similares
-
Romiplostim-related myelofibrosis in refractory primary immune thrombocytopenia: A Case report
por: Kim, Hyun-Young, et al.
Publicado: (2019) -
Bilateral ovarian granulocytic sarcoma as the primary manifestation of acute myelogenous leukemia treated with allogenic stem cell transplantation: A case report
por: Choi, Jung Yoon, et al.
Publicado: (2019) -
Gemcitabine-Containing Chemotherapy for the Treatment of Metastatic Myxofibrosarcoma Refractory to Doxorubicin: A Case Series
por: Elkrief, Arielle, et al.
Publicado: (2021) -
A comparison of pectoralis versus lumbar skeletal muscle indices for defining sarcopenia in diffuse large B-cell lymphoma - two are better than one
por: Go, Se-Il, et al.
Publicado: (2017) -
Remarkable response to anti-PD1 immunotherapy in refractory metastatic high-grade myxofibrosarcoma patient: A case report
por: Luo, Yi, et al.
Publicado: (2021)